In the coming weeks, one of the most impactful and controversial classes for the Hall of Fame will have judgment passed on them—at least for their first year of eligibility. One of those on the list is all-time home run leader Barry Bonds, whose career, despite being acquitted of any wrongdoing in a court of law, will forever be tied to the steroid era.

Bonds is certainly a huge part of the San Francisco Giants history and although not being part of the teams’ two recent (and only) World Series titles, his name and his actions still set off widespread debate amongst Bay Area faithful.

Should he get in, should he not.

An election to the Hall would also benefit the Giants’ brand, who could use that justification for even more business gains in an area where baseball is really rivaled only by the success of the 49ers in popularity. Will the Giants take a stand in the “should he or shouldn’t he go to the Hall” debate?

Team CEO Larry Baer talked about the possibility of Bonds getting into the Hall of Fame, as well as the benefits of the decline of the steroid era on Bloomberg Television’s “Money Moves” this weekend.

“We don’t have a vote; it’s the baseball writers who will make that call,” Baer said on the show. “You have to look at the accomplishments he had over the length of his career and then establish the criteria from the era which he played in. When that is set then we can make a fair judgment.”

Baer did go on to say that he thought MLB has done great work bringing the steroid era to an end and that the policies work, even though they did cost the team their star outfielder Melky Cabrera for the better part of the last two months of their surprising run to the 2012 title.

Will we see Barry Bonds Way adjacent to McCovey Cove any time soon? Apparently, the team will take a wait and see attitude with their star crossed home run king, and will let the writers make the decision for them in the coming months.

Read more MLB news on